Device Oncology

Microthermx Microwave Ablation System

Payments companies reported to CMS as associated with Microthermx Microwave Ablation System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$40Kassociated payments (2023-2025)
314clinicians with associated payments
1company reporting

By year

2023 $11K
2024 $5,160
2025 $24K

Payments reported as associated with Microthermx Microwave Ablation System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $28K
Diagnostic Radiology $7,849
Physician Assistant $1,083
Surgical Oncology $693
Surgery $502
Medical $314

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Microthermx Microwave Ablation System

These are the largest totals companies reported as associated with Microthermx Microwave Ablation System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Venkatesh Krishnasamy Birmingham, AL Vascular & Interventional Radiology $8,295.83
Edward Kim New York, NY Vascular & Interventional Radiology $4,286.27
Amy Deipolyi Charleston, WV Vascular & Interventional Radiology $3,000.00
Constantinos Sofocleous New York, NY Diagnostic Radiology $1,901.16
Sadeer Alzubaidi Scottsdale, AZ Diagnostic Radiology $524.80
Jason Williams Jackson, MS Diagnostic Radiology $372.33
Henderson Jones Scottsdale, AZ Vascular & Interventional Radiology $312.17
Chijioke Iwuchukwu Scottsdale, AZ Vascular & Interventional Radiology $302.18
Osman Tahir Mount Clemens, MI Diagnostic Radiology $296.62
Henry Krebs Newnan, GA Diagnostic Radiology $271.21

Prescribed Microthermx Microwave Ablation System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.